NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
Estimated value
£1
Awarded value
£188.0m
Suppliers
1
Lots
1
Published
17 Oct 2019
Description
NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals (Doravirine only) for Midlands & East and North of England. Offer reference number: CM/PHR/16/5521 CM/PHR/16/5521/01 - NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Period of framework: 1 September 2019 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines - Annual Tranche - Cytokine Modulators and other monoclonal antibodies, Period of framework: 1 September 2019 to 31 August 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 - Midlands & East and North of England, Period of framework agreement: Midlands & East 1 September 2019 to 29 February 2020: North of England 1 September 2019 to 28 February 2021
Scope
- Reference
- tender_192057/789821
- Total value
- £1 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2019 to 30 Aug 2021
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 14 Apr 2019, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£188.0m
Award date
31 Jul 2019
Contract start
31 Aug 2019
Contract end
30 Aug 2021